Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 15,211Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 20Eli Lilly

02 2Loxo Oncology Inc

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

SELPERCATINIB

Brand Name : RETEVMO

Dosage Form : CAPSULE;ORAL

Dosage Strength : 40MG

Packaging :

Approval Date : 2020-05-08

Application Number : 213246

Regulatory Info : RX

Registration Country : USA

blank

02

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

SELPERCATINIB

Brand Name : RETEVMO

Dosage Form : CAPSULE;ORAL

Dosage Strength : 80MG

Packaging :

Approval Date : 2020-05-08

Application Number : 213246

Regulatory Info : RX

Registration Country : USA

blank

03

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

SELPERCATINIB

Brand Name : RETEVMO

Dosage Form : TABLET;ORAL

Dosage Strength : 40MG

Packaging :

Approval Date : 2024-04-10

Application Number : 218160

Regulatory Info : RX

Registration Country : USA

blank

04

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

SELPERCATINIB

Brand Name : RETEVMO

Dosage Form : TABLET;ORAL

Dosage Strength : 80MG

Packaging :

Approval Date : 2024-04-10

Application Number : 218160

Regulatory Info : RX

Registration Country : USA

blank

05

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

SELPERCATINIB

Brand Name : RETEVMO

Dosage Form : TABLET;ORAL

Dosage Strength : 120MG

Packaging :

Approval Date : 2024-04-10

Application Number : 218160

Regulatory Info : RX

Registration Country : USA

blank

06

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

SELPERCATINIB

Brand Name : RETEVMO

Dosage Form : TABLET;ORAL

Dosage Strength : 160MG

Packaging :

Approval Date : 2024-04-10

Application Number : 218160

Regulatory Info : RX

Registration Country : USA

blank

07

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

SELPERCATINIB

Brand Name : RETEVMO

Dosage Form : CAPSULE;ORAL

Dosage Strength : 40MG

Packaging :

Approval Date :

Application Number : 218160

Regulatory Info :

Registration Country : USA

blank

08

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

SELPERCATINIB

Brand Name : RETEVMO

Dosage Form : CAPSULE;ORAL

Dosage Strength : 80MG

Packaging :

Approval Date :

Application Number : 218160

Regulatory Info :

Registration Country : USA

blank

09

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Selpercatinib

Brand Name : Retsevmo

Dosage Form : Film Coated Tablet

Dosage Strength : 120mg

Packaging :

Approval Date : 23/04/2025

Application Number : 20240312000136

Regulatory Info : Approved

Registration Country : Sweden

blank

10

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Selpercatinib

Brand Name : Retsevmo

Dosage Form : Film Coated Tablet

Dosage Strength : 160mg

Packaging :

Approval Date : 23/04/2025

Application Number : 20240312000143

Regulatory Info : Approved

Registration Country : Sweden

blank

11

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Selpercatinib

Brand Name : Retsevmo

Dosage Form : Film Coated Tablet

Dosage Strength : 40mg

Packaging :

Approval Date : 23/04/2025

Application Number : 20240312000112

Regulatory Info : Approved

Registration Country : Sweden

blank

12

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Selpercatinib

Brand Name : Retsevmo

Dosage Form : Capsule

Dosage Strength : 40mg

Packaging :

Approval Date : 11/02/2021

Application Number : 20191224000014

Regulatory Info : Approved

Registration Country : Sweden

blank

13

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Selpercatinib

Brand Name : Retsevmo

Dosage Form : Film Coated Tablet

Dosage Strength : 80mg

Packaging :

Approval Date : 23/04/2025

Application Number : 20240312000129

Regulatory Info : Approved

Registration Country : Sweden

blank

14

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Selpercatinib

Brand Name : Retsevmo

Dosage Form : Capsule

Dosage Strength : 80mg

Packaging :

Approval Date : 11/02/2021

Application Number : 20191224000021

Regulatory Info : Approved

Registration Country : Sweden

blank

15

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Selpercatinib

Brand Name : Retsevmo

Dosage Form : Capsule

Dosage Strength : 40mg

Packaging :

Approval Date : 08/02/2021

Application Number : 67862

Regulatory Info : Allowed

Registration Country : Switzerland

blank

16

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Selpercatinib

Brand Name : Retsevmo

Dosage Form : Capsule

Dosage Strength : 80mg

Packaging :

Approval Date : 08/02/2021

Application Number : 67862

Regulatory Info : Allowed

Registration Country : Switzerland

blank

17

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Selpercatinib

Brand Name : Retsevmo

Dosage Form : Hard Capsule

Dosage Strength : 80MG

Packaging :

Approval Date : 2021-03-04

Application Number : 1201527002

Regulatory Info : Authorized

Registration Country : Spain

blank

18

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Selpercatinib

Brand Name : Retsevmo

Dosage Form : Hard Capsule

Dosage Strength : 40MG

Packaging :

Approval Date : 2021-03-04

Application Number : 1201527001

Regulatory Info : Authorized

Registration Country : Spain

blank

19

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

SELPERCATINIB

Brand Name : RETEVMO

Dosage Form : CAPSULE

Dosage Strength : 40MG

Packaging :

Approval Date :

Application Number : 2516918

Regulatory Info : Prescription

Registration Country : Canada

blank

20

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

SELPERCATINIB

Brand Name : RETEVMO

Dosage Form : CAPSULE

Dosage Strength : 80MG

Packaging :

Approval Date :

Application Number : 2516926

Regulatory Info : Prescription

Registration Country : Canada

blank